Aplastic anemia
Aplastic anemia (AA) is a disease in which the bone marrow hematopoietic stem cells and the bone marrow microenvironment are severely damaged by physical, chemical, biological or unknown factors, resulting in a decrease or failure of the bone marrow hematopoietic function. It is a group of syndromes with pancytopenia as the main manifestation. According to a survey in 21 provinces (cities) and autonomous regions in China, the annual incidence rate is 0.74/100,000 population, which is significantly lower than the incidence rate of leukemia; the incidence rate of chronic aplastic anemia is 0.60/100,000 population, and the incidence rate of acute aplastic anemia is 0.14/100,000 population; it can occur in all age groups, but it is more common in young and middle-aged people; the incidence rate in men is slightly higher than that in women.
-
Site of disease:
Bone marrow blood vessels
-
Infectious :
Not contagious
-
Frequent population:
Young adults, mostly males
-
Related symptoms:
Gastrointestinal bleeding
retinal bleeding and exudation
visceral bleeding
bleeding tendency
fatigue
Related Drugs
Mannan peptide tablets
Indication: Used as an adjuvant treatment for immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumor treatment, and to reduce the side effects of radiotherapy and chemotherapy on the hematopoietic system and gastrointestinal reactions.
Mannan peptide tablets
Indication: Used as an adjuvant treatment for immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumor treatment, and to reduce the side effects of radiotherapy and chemotherapy on the hematopoietic system and gastrointestinal reactions.
Manufacturer:
Tonghua Jinhui Pharmaceutical Co., Ltd.
Mannan peptide tablets
Indication: Used as an adjuvant treatment for immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumor treatment, and to reduce the side effects of radiotherapy and chemotherapy on the hematopoietic system and gastrointestinal reactions.
Manufacturer:
Jilin Wantong Pharmaceutical Group Meihe Pharmaceutical Co., Ltd.
Mannan peptide tablets
Indication: Used as an adjuvant treatment for immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumor treatment, and to reduce the side effects of radiotherapy and chemotherapy on the hematopoietic system and gastrointestinal reactions.
Manufacturer:
Guangdong Hongyuan Group Pharmaceutical Co., Ltd.
Mannan peptide tablets
Indication: Used as an adjuvant treatment for immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumor treatment, and to reduce the side effects of radiotherapy and chemotherapy on the hematopoietic system and gastrointestinal reactions.
Manufacturer:
Hainan Pharmaceutical FACTORY Co., Ltd.
Mannan peptide tablets
Indication: Used as an adjuvant treatment for immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumor treatment, and to reduce the side effects of radiotherapy and chemotherapy on the hematopoietic system and gastrointestinal reactions.
Manufacturer:
Letai Pharmaceutical Co., Ltd.
Mannan peptide tablets
Indication: Used as an adjuvant treatment for immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumor treatment, and to reduce the side effects of radiotherapy and chemotherapy on the hematopoietic system and gastrointestinal reactions.
Mannan peptide oral solution
Indication: Used for adjuvant treatment of immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumors, and to reduce the adverse reactions of radiotherapy and chemotherapy to the hematopoietic system and gastrointestinal reactions
Manufacturer:
Jiangxi Qingfeng Pharmaceutical Co., Ltd.
Mannan peptide oral solution
Indication: Used for adjuvant treatment of immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumors, and to reduce the adverse reactions of radiotherapy and chemotherapy to the hematopoietic system and gastrointestinal reactions
Manufacturer:
Letai Pharmaceutical Co., Ltd.
Mannan peptide oral solution
Indication: Used for adjuvant treatment of immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumors, and to reduce the adverse reactions of radiotherapy and chemotherapy to the hematopoietic system and gastrointestinal reactions
Manufacturer:
Chongqing Jirui Pharmaceutical Co., Ltd.